These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 7691092

  • 1. Effect of pituitary adenylate cyclase activating polypeptide on vasopressin-induced proliferation of aortic smooth muscle cells: comparison with vasoactive intestinal polypeptide.
    Oiso Y, Kotoyori J, Murase T, Ito Y, Kozawa O.
    Biochem Cell Biol; 1993; 71(3-4):156-61. PubMed ID: 7691092
    [Abstract] [Full Text] [Related]

  • 2. Pituitary adenylate cyclase-activating polypeptide induces cAMP production independently from vasoactive intestinal polypeptide in osteoblast-like cells.
    Suzuki A, Kotoyori J, Oiso Y, Kozawa O.
    Cell Signal; 1994 Jan; 6(1):11-6. PubMed ID: 7912096
    [Abstract] [Full Text] [Related]

  • 3. Rat aortic smooth-muscle cell proliferation is bidirectionally regulated in a cell cycle-dependent manner via PACAP/VIP type 2 receptor.
    Miyata A, Sato K, Hino J, Tamakawa H, Matsuo H, Kangawa K.
    Ann N Y Acad Sci; 1998 Dec 11; 865():73-81. PubMed ID: 9927999
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pituitary adenylate cyclase-activating polypeptide stimulates steroidogenesis and adenosine 3',5'-monophosphate accumulation in cultured rat granulosa cells.
    Zhong Y, Kasson BG.
    Endocrinology; 1994 Jul 11; 135(1):207-13. PubMed ID: 8013355
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Vasoactive intestinal peptide and pituitary adenylyl cyclase-activating polypeptide inhibit tumor necrosis factor-alpha production in injured spinal cord and in activated microglia via a cAMP-dependent pathway.
    Kim WK, Kan Y, Ganea D, Hart RP, Gozes I, Jonakait GM.
    J Neurosci; 2000 May 15; 20(10):3622-30. PubMed ID: 10804204
    [Abstract] [Full Text] [Related]

  • 15. Pituitary adenylate cyclase-activating polypeptide modulates gastric enterochromaffin-like cell proliferation in rats.
    Läuffer JM, Modlin IM, Hinoue T, Kidd M, Zhang T, Schmid SW, Tang LH.
    Gastroenterology; 1999 Mar 15; 116(3):623-35. PubMed ID: 10029621
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. II: Effects of the pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide.
    Aoki Y, Iwasaki Y, Katahira M, Oiso Y, Saito H.
    Endocrinology; 1997 May 15; 138(5):1930-4. PubMed ID: 9112389
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.